Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types
Background: In 2008, the UK introduced an HPV immunisation programme in girls. Population-based prevalence estimates of bivalent (HPV-16/18), quadrivalent (HPV-6/11/16/18) and 9-valent (HPV-6/11/16/18/31/33/45/52/58) vaccine types, and comparison over time, are needed to monitor impact, evaluate eff...
Main Authors: | Clare Tanton, David Mesher, Simon Beddows, Kate Soldan, Soazig Clifton, Kavita Panwar, Nigel Field, Catherine H. Mercer, Anne M. Johnson, Pam Sonnenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-06-01
|
Series: | Papillomavirus Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405852116300350 |
Similar Items
-
HPV Serology Testing Confirms High HPV Immunisation Coverage in England.
by: David Mesher, et al.
Published: (2016-01-01) -
Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico.
by: Ana Patricia Ortiz, et al.
Published: (2017-01-01) -
Cost-effectiveness analysis of the bivalent and quadrivalent human papillomavirus vaccines from a societal perspective in Colombia.
by: Johanna Aponte-González, et al.
Published: (2013-01-01) -
Assessment of the population-level impact of a high coverage HPV immunisation programme in young females
by: Mesher, D.
Published: (2018) -
Correction: Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico.
by: Ana Patricia Ortiz, et al.
Published: (2018-01-01)